Diagnostic Testing for Suspected CNS Vasculitis
For suspected central nervous system vasculitis, obtain brain MRI with vessel wall imaging (VWI) and lumbar puncture first, followed by cerebral angiography (MRA or CTA) to assess for vascular stenosis, and strongly consider brain/meningeal biopsy as the gold standard—particularly when imaging is equivocal or shows small vessel involvement.
Algorithmic Diagnostic Approach
Step 1: Initial Non-Invasive Testing
Brain MRI with specialized sequences:
- Standard brain MRI is abnormal in 93% of CNS vasculitis cases 1
- Add vessel wall imaging (VWI) sequences to detect vessel wall contrast enhancement (VW-CE), which appears in nearly all cases with visible stenosis 2
- VW-CE is typically concentric (88%) rather than eccentric in CNS vasculitis 2
- Black blood technique specifically helps confirm vascular wall involvement 3
Lumbar puncture:
- CSF abnormalities present in 74% of cases 1
- Essential for excluding infectious mimics and supporting inflammatory diagnosis 3, 4
Step 2: Vascular Imaging
Non-invasive angiography (MRA or CTA):
- Identifies stenoocclusive lesions in medium-to-large vessel disease 2
- Critical caveat: Normal angiography does NOT exclude CNS vasculitis—14% of biopsy-proven cases have normal angiography 1
Digital subtraction angiography (DSA):
- Historically considered the "gold standard" but has significant limitations
- When both DSA and biopsy performed, they disagree more than 5 times as often as they agree 1
- 10.6% of patients with abnormal angiography had normal biopsies 1
- May have limited added benefit beyond MRA/CTA when clinical and laboratory findings are considered 5
Step 3: Tissue Diagnosis
Brain or meningeal biopsy:
- Remains the true gold standard, especially for small vessel involvement 6, 4
- Targets leptomeningeal and superficial cortical vessels 6
- Diagnostic criteria require transmural inflammation and vascular wall damage 6
- Should be "discussed as often as possible" per recent French guidelines 4
- Essential when: MRA-negative disease, equivocal imaging findings, or need to exclude mimics (infection, malignancy, other inflammatory conditions) 3, 6, 7
Key Diagnostic Patterns
MRA-positive disease (visible stenosis):
- Nearly 100% show VW-CE on vessel wall imaging 2
- 79% of stenoses demonstrate VW-CE 2
- Diffusion-restricted lesions more common with stenoses showing VW-CE 2
MRA-negative disease (no visible stenosis):
- Only 12% (2/17) show VW-CE 2
- Higher threshold for biopsy in this group since imaging less reliable
Critical Pitfalls to Avoid
Do not rely on angiography alone: Only 4.6% of cases with classic angiographic features had pathologic confirmation when both tests performed 1
Do not assume VW-CE equals active inflammation: Follow-up studies show VW-CE can persist despite immunosuppressive therapy and clinical remission 2—it may represent remodeling rather than active disease
Do not skip biopsy in diagnostically uncertain cases: The differential diagnosis is broad (infections, malignancy, other inflammatory diseases), and biopsy with appropriate immunohistochemistry and special stains is critical for definitive diagnosis 6, 7
Recognize the trend away from tissue diagnosis: Published cases show increasing reliance on angiography and decreasing use of biopsy over time 1—this may lead to misdiagnosis given the poor agreement between tests
Ancillary Testing
- Routine laboratory tests to exclude systemic vasculitis and autoimmune disorders 3
- Special laboratory biomarkers (though none are specific for CNS vasculitis) 3
- Echocardiography if aortitis suspected in large vessel variants 8
The multidisciplinary team should include neurology, neuroradiology, and rheumatology/immunology 3, 4, with biopsy interpretation by experienced neuropathologists familiar with vasculitis mimics 6.